Status:
RECRUITING
The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament
Lead Sponsor:
British University In Egypt
Conditions:
Endodontic Disease
Pulp Disease, Dental
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
PHASE3
Brief Summary
The goal of this randomized clinical trial is to evaluate the capability of the material to exert bacterial reduction of diclofenac sodium versus of that calcium hydroxide paste when these materials a...
Detailed Description
The aim of the present study is to evaluate the capability of the material to exert bacterial reduction of diclofenac sodium versus of that calcium hydroxide paste when these materials are used as int...
Eligibility Criteria
Inclusion
- Patients with teeth diagnosed with apical periodontitis
- Periapical Index (PAI) ≥ 2
- The teeth are restorable
Exclusion
- Teeth with immature roots
- Non restorable teeth
- Medically compromised patients with systemic complication that would alter the treatment.
- Teeth with internal/external root resorption
- Patient with an allergy to diclofenac sodium
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06207253
Start Date
November 1 2025
End Date
December 1 2025
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British university in Egypt
Cairo, Egypt